David S. Tierney, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 20,000 shares at $14.16 ($283K) on 2022-08-22, disclosed to the SEC on 2022-08-23.
Open-market sale of $283k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2024-04-10 | $392K | — | Filing → |
| CPRX | SELL | 2023-12-14 | $667K | — | Filing → |
| CPRX | SELL | 2023-04-07 | $1.0M | — | Filing → |